Townsville University Hospital, formerly The Townsville Hospital, is a public tertiary care hospital on Angus Smirth Drive, Douglas, Townsville, Queensland, Australia. It is the largest facility within the Townsville Hospital and Health Service geographic area.

During the past decade, Townsville Hospital conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 15 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 12 clinical trials were completed. i.e. 70.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Townsville Hospital" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Trans Tasman Radiation Oncology Group" with 5 trials sponsored, "University of Sydney" with 5 trials sponsored, "Queensland Centre for Gynaecological Cancer" with 4 trials sponsored and "Australian and New Zealand Intensive Care Research Centre" with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Townsville Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 10 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 5 trials as a collaborator, "Australian Red Cross" with 3 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 3 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 92 trials.

According to Clinical.Site data, the most researched conditions in "Townsville Hospital" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Bladder Cancer" (2 trials), "Breast Cancer" (2 trials), "Coagulopathy" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Townsville Hospital" in a lesser frequency.

Most popular intervention types in "Townsville Hospital" are "Drug" (54 trials), "Other" (12 trials), "Radiation" (9 trials), "Procedure" (7 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Cisplatin" (7 trials), "Paclitaxel" (7 trials), "Carboplatin" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Townsville Hospital" are 58 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Townsville Hospital". undefined are not yet recruiting, 16 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Townsville Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Townsville Hospital, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".